Skip to main content
NovoRapid® Penfill supply mitigation; supply of stock with old patient information leaflet
For Healthcare Professionals
To ensure continuity in supply, Nordisk A/S has obtained approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to supply stock packaged with the old patient information leaflet, product batch LR77A19 (74640 packs) and batch LR77D24 (27120 packs)
which is expected to be on Great Britain market for a period of seven weeks from 7th November to 31st December 2022.
